News

Article

Bruder Healthcare names Steven Fusco national account director

Author(s):

According to the company, Steven Fusco will focus on Bruder Healthcare and Hilco Vision product portfolios.

Fusco has experience building revenue growth and commercial success in the eyecare industry. (Image courtesy of Adobe Stock)

Fusco has experience building revenue growth and commercial success in the eyecare industry. (Image courtesy of Adobe Stock)

Bruder Healthcare announced today of Steven Fusco to its team as the national account director.

In the new role, Fusco will develop initiatives, foster partnerships, and accelerate growth opportunities to expand the company's reach and impact within the eye care sector.

According to a news release, Fusco has experience building revenue growth and commercial success in the eyecare industry. Prior to joining Bruder Healthcare, he served as the senior director of Business Development at Lexitas, an ophthalmic product development company and co-founder of MYZE, an eye care patient engagement platform. He held sales management positions with Santen, an eye care pharmaceutical company, and Eyevance, an ophthalmic products firm later acquired by Santen. Fusco's experience also includes sales and business development roles for medical lab company Quest Diagnostics.

"Steven’s eyecare industry experience combined with his ability to drive growth and innovation align perfectly with our company's mission and message, where we encourage doctors and patients alike to “Open Your Eyes to Bruder”, Brent Jones, general manager of Bruder Healthcare and Global Head of Dry Eye at Hilco Vision, said in the news release.

Bruder Healthcare designs and markets therapeutic and ophthalmic products to healthcare professionals and consumers worldwide, including a moist heat eye compress. Its product line is focused on issues of muscle pain, dry eye, and other ocular conditions.

Hilco Vision is a global eyewear and eye care company that delivers comprehensive solutions to customers.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
Patricia Buehler, MD, MPH, founder and CEO of Osheru, talks about the Ziplyft device for noninvasive blepharoplasty at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Bonnie An Henderson, MD, on leveraging artificial intelligence in cataract refractive surgery
(Image credit: Ophthalmology Times) ASCRS 2025: Gregory Moloney, FRANZO, FRCSC, on rotational stability
Sheng Lim, MD, FRCOphth, discusses the CONCEPT study, which compared standalone cataract surgery to cataract surgery with ECP, at the 2025 ASCRS Annual Meeting.
(Image credit: Ophthalmology Times) ASCRS 2025: Steven J. Dell, MD, reports 24-month outcomes for shape-changing IOL
© 2025 MJH Life Sciences

All rights reserved.